Table 2. The negative controls and the number of the serum samples were examined for the specificity evaluation in this study.
| ELISA results | Biosensor results (|ΔθSPR|) | ||||||
|---|---|---|---|---|---|---|---|
| Type of sample | Patient serum | NS1 | IgM | S.T. 1 | S.T. 2 | S.T. 3 | S.T. 4 |
| Tick-Borne Encephalitis | SAM01 | − | − | 0.31852 | 0.3760 | 0.19469 | 0.32879 |
| SAM02 | − | − | 0.15085 | 0.2557 | 0.21550 | 0.19386 | |
| SAM 03 | − | − | 0.37746 | 0.2860 | 0.00040 | 0.19946 | |
| SAM 04 | − | − | 0.16855 | 0.2940 | 0.04890 | 0.16955 | |
| SAM 05 | − | − | 0.14738 | 0.1254 | 0.02943 | 0.13294 | |
| SAM 06 | − | − | 0.02807 | 0.1651 | 0.25771 | 0.08001 | |
| SAM 07 | − | − | 0.25098 | 0.0770 | 0.18170 | 0.10140 | |
| SAM 08 | − | − | 0.03523 | 0.0973 | 0.02780 | 0.07478 | |
| SAM 09 | − | − | 0.04094 | 0.0646 | 0.07810 | 0.04010 | |
| SAM 10 | − | − | 0.05042 | 0.0050 | 0.01400 | 0.01260 | |
| SAM 11 | − | − | 0.24308 | 0.0911 | 0.25786 | 0.04538 | |
| SAM 12 | − | − | 0.11004 | 0.0011 | 0.25924 | 0.09303 | |
| SAM 13 | − | − | 0.25980 | 0.1937 | 0.21978 | 0.09314 | |
| SAM 14 | − | − | 0.35171 | 0.2944 | 0.31243 | 0.20877 | |
| SAM 15 | − | − | 0.2852 | 0.1905 | 0.23039 | 0.10882 | |
| SAM 16 | − | − | 0.21199 | 0.1115 | 0.14507 | 0.01650 | |
| SAM 17 | − | − | 0.22769 | 0.1312 | 0.17126 | 0.03061 | |
| SAM 18 | − | − | 0.28431 | 0.1407 | 0.15434 | 0.00509 | |
| SAM 19 | − | − | 0.25883 | 0.1396 | 0.17210 | 0.04012 | |
| Hepatitis C | SAM 20 | − | − | 0.21092 | 0.1737 | 0.23510 | 0.11329 |
| SAM 21 | − | − | 0.23587 | 0.1497 | 0.24237 | 0.09972 | |
| SAM 22 | − | − | 0.30437 | 0.1798 | 0.19558 | 0.06360 | |